Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Mammographic screening for breast cancer in a resource-restricted environment.

Apffelstaedt SP, Dalmayer L, Baatjes K.

S Afr Med J. 2014 Apr;104(4):294-6.

PMID:
25118556
2.

Evaluation of appropriate short-term mammographic surveillance in patients who undergo breast-conserving Surgery (BCS).

Gunia SR, Merrigan TL, Poulton TB, Mamounas EP.

Ann Surg Oncol. 2012 Oct;19(10):3139-43. doi: 10.1245/s10434-012-2578-x. Epub 2012 Aug 8.

PMID:
22872291
3.

Surgeon-read screening mammography: an analysis of 11,948 examinations.

Apffelstaedt JP, Steenkamp V, Baatjes KJ.

Ann Surg Oncol. 2010 Oct;17 Suppl 3:249-54. doi: 10.1245/s10434-010-1241-7. Epub 2010 Sep 19.

PMID:
20853042
4.

Results of a pilot programme of mammographic breast cancer screening in the Western Cape.

Apffelstaedt JP, Hattingh R, Baatjes K, Wessels N.

S Afr Med J. 2014 Apr;104(4):297-8.

PMID:
25118557
5.

Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.

Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S, Tuttobene P, Bricolo P, Fantò C, Valentini M, Montemezzi S, Macaskill P.

Lancet Oncol. 2013 Jun;14(7):583-9. doi: 10.1016/S1470-2045(13)70134-7. Epub 2013 Apr 25.

PMID:
23623721
6.

Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.

Bernardi D, Macaskill P, Pellegrini M, Valentini M, Fantò C, Ostillio L, Tuttobene P, Luparia A, Houssami N.

Lancet Oncol. 2016 Aug;17(8):1105-13. doi: 10.1016/S1470-2045(16)30101-2. Epub 2016 Jun 23.

PMID:
27345635
7.

Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.

Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW.

Breast Cancer Res. 2012 Jan 9;14(1):R10.

8.

Staging of breast cancer with ultrasound.

Yang WT.

Semin Ultrasound CT MR. 2011 Aug;32(4):331-41. doi: 10.1053/j.sult.2011.02.008. Review.

PMID:
21782123
9.

Screening mammography following autologous breast reconstruction: an unnecessary effort.

Freyvogel M, Padia S, Larson K, Dietz J, Grobmyer S, O'Rourke C, Valente S.

Ann Surg Oncol. 2014 Oct;21(10):3256-60. doi: 10.1245/s10434-014-3913-1. Epub 2014 Jul 25.

PMID:
25059787
10.

Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.

Újhelyi M, Pukancsik D, Kelemen P, Kovács E, Kenessey I, Udvarhelyi N, Bak M, Kovács T, Mátrai Z.

Eur J Surg Oncol. 2016 Dec;42(12):1814-1820. doi: 10.1016/j.ejso.2016.06.403. Epub 2016 Jul 9.

PMID:
27424787
11.

[Impact of breast ultrasound screening in gynecological practice].

Madjar H, Becker S, Doubek K, Horchler T, Mendoza M, Moisidis-Tesch C, Näther B, Niebling K, Pröls U, Schardt AR, Ulrich S, Zahn U.

Ultraschall Med. 2010 Jun;31(3):289-95. doi: 10.1055/s-0028-1110010. Epub 2010 Apr 20. German.

PMID:
20408119
12.

Diagnostic value of breast ultrasound in mammography BI-RADS 0 and clinically indeterminate or suspicious of malignancy breast lesions.

Dobrosavljević A, Rakić S, Nikoli B, Raznatović SJ, Dikić SD, Milosević Z, Jurisić A, Skrobić M.

Vojnosanit Pregl. 2016 Mar;73(3):239-45.

PMID:
27295907
13.

Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases.

Farshid G, Sullivan T, Downey P, Gill PG, Pieterse S.

Br J Cancer. 2011 Nov 22;105(11):1669-75. doi: 10.1038/bjc.2011.466. Epub 2011 Nov 3.

14.

Clinical outcome assessment in mammography: an audit of 7,506 screening and diagnostic mammography examinations.

Tunçbilek I, Ozdemir A, Gültekin S, Oğur T, Erman R, Yüce C.

Diagn Interv Radiol. 2007 Dec;13(4):183-7.

15.

Biennial versus annual mammography and the risk of late-stage breast cancer.

White E, Miglioretti DL, Yankaskas BC, Geller BM, Rosenberg RD, Kerlikowske K, Saba L, Vacek PM, Carney PA, Buist DS, Oestreicher N, Barlow W, Ballard-Barbash R, Taplin SH.

J Natl Cancer Inst. 2004 Dec 15;96(24):1832-9.

PMID:
15601639
16.

The importance of pre-operative needle core breast biopsy results on resected tissue volume, margin status, and cosmesis.

Polat AV, Soran A, Andacoglu O, Kamali Polat A, McGuire K, Diego E, Johnson R.

J BUON. 2013 Jul-Sep;18(3):601-7.

PMID:
24065470
17.

Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.

Goldenberg DM, Abdel-Nabi H, Sullivan CL, Serafini A, Seldin D, Barron B, Lamki L, Line B, Wegener WA.

Cancer. 2000 Jul 1;89(1):104-15.

PMID:
10897007
18.

Mammorgraphy reporting at Tygerberg hospital, Cape Town, South Africa.

Pitcher R, Lotz J, Ackermann C, Bagadia A, Davis R, du Plessis AM, Griffith-Richards S, Hattingh R, Wagener G.

S Afr Med J. 2014 Jul;104(7):456. No abstract available.

PMID:
25298984
19.

Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.

Weaver DL, Rosenberg RD, Barlow WE, Ichikawa L, Carney PA, Kerlikowske K, Buist DS, Geller BM, Key CR, Maygarden SJ, Ballard-Barbash R.

Cancer. 2006 Feb 15;106(4):732-42.

20.

Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer.

Adrada BE, Huo L, Lane DL, Arribas EM, Resetkova E, Yang W.

Ann Surg Oncol. 2015 Apr;22(4):1111-7. doi: 10.1245/s10434-014-4113-8. Epub 2014 Oct 7.

PMID:
25287438

Supplemental Content

Support Center